M H Bar

622 total citations
11 papers, 421 citations indexed

About

M H Bar is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M H Bar has authored 11 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M H Bar's work include Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (5 papers). M H Bar is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (5 papers). M H Bar collaborates with scholars based in United States, Germany and Malaysia. M H Bar's co-authors include Mario Sznol, Ellen R. Gaynor, Geoffrey R. Weiss, Kim Margolin, David H. Boldt, Frederick R. Aronson, Michael B. Atkins, James H. Doroshow, Richard I. Fisher and J W Mier and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and American Journal of Roentgenology.

In The Last Decade

M H Bar

11 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M H Bar United States	8	258	227	89	64	44	11	421
S. Kudoh Japan	7	257 1.0×	444 2.0×	46 0.5×	87 1.4×	54 1.2×	12	578
Nicholas P. Schaub United States	8	222 0.9×	142 0.6×	48 0.5×	66 1.0×	67 1.5×	8	403
Anna‐Kaisa Eerola Finland	6	264 1.0×	125 0.6×	66 0.7×	182 2.8×	39 0.9×	7	407
Ronald L. P. van Vlierberghe Netherlands	10	168 0.7×	156 0.7×	50 0.6×	96 1.5×	30 0.7×	18	396
Takako Suda Japan	11	136 0.5×	140 0.6×	70 0.8×	117 1.8×	106 2.4×	25	391
Daniele Pozzessere Italy	14	230 0.9×	103 0.5×	175 2.0×	114 1.8×	43 1.0×	24	426
John T. Bickel United States	11	84 0.3×	103 0.5×	89 1.0×	84 1.3×	93 2.1×	25	414
Eunice H. Rhee United States	5	133 0.5×	106 0.5×	85 1.0×	92 1.4×	127 2.9×	5	403
Yuji Hirami Japan	10	222 0.9×	145 0.6×	162 1.8×	96 1.5×	32 0.7×	21	405
T Mørk Norway	6	177 0.7×	81 0.4×	66 0.7×	29 0.5×	62 1.4×	15	343

Countries citing papers authored by M H Bar

Since Specialization

Citations

This map shows the geographic impact of M H Bar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M H Bar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M H Bar more than expected).

Fields of papers citing papers by M H Bar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M H Bar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M H Bar. The network helps show where M H Bar may publish in the future.

Co-authorship network of co-authors of M H Bar

This figure shows the co-authorship network connecting the top 25 collaborators of M H Bar. A scholar is included among the top collaborators of M H Bar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M H Bar. M H Bar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Ziemssen, Tjalf, Andrea Bauer, & M H Bar. (2008). Potential side effect of high-dose corticosteroid relapse treatment: acute generalized exanthematous pustulosis (AGEP). Multiple Sclerosis Journal. 15(2). 275–277. 7 indexed citations

Yefenof, Eitan, et al.. (1995). Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K. Cancer Immunology Immunotherapy. 41(6). 389–396. 19 indexed citations

Weiss, Geoffrey R., Kim Margolin, Frederick R. Aronson, et al.. (1992). A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.. Journal of Clinical Oncology. 10(2). 275–281. 104 indexed citations

Saxon, Richard R., M H Bar, Paul D. Blanc, et al.. (1991). Pathogenesis of pulmonary edema during interleukin-2 therapy: correlation of chest radiographic and clinical findings in 54 patients.. American Journal of Roentgenology. 156(2). 281–285. 27 indexed citations

Dutcher, Janice P., Ellen R. Gaynor, David H. Boldt, et al.. (1991). A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma.. Journal of Clinical Oncology. 9(4). 641–648. 78 indexed citations

Gaynor, Ellen R., Geoffrey R. Weiss, Kim Margolin, et al.. (1990). Phase I Study of High-Dose Continuous-Infusion Recombinant Interleukin-2 and Autologous Lymphokine-Activated Killer Cells in Patients With Metastatic or Unresectable Malignant Melanoma and Renal Cell Carcinoma. JNCI Journal of the National Cancer Institute. 82(17). 1397–1402. 34 indexed citations

Bar, M H, Mario Sznol, Michael B. Atkins, et al.. (1990). Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells.. Journal of Clinical Oncology. 8(7). 1138–1147. 66 indexed citations

Parkinson, David, Richard I. Fisher, Anthony A. Rayner, et al.. (1990). Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen.. Journal of Clinical Oncology. 8(10). 1630–1636. 66 indexed citations

Woźniak, Katarzyna & M H Bar. (1990). [Significance of skin changes in diabetes mellitus].. PubMed. 45(22). 669–73. 1 indexed citations

10.

Sznol, Mario, J W Mier, Joseph A. Sparano, et al.. (1990). A phase I study of high-dose interleukin-2 in combination with interferon-alpha 2b.. PubMed. 9(6). 529–37. 18 indexed citations

11.

Gaynor, Ellen R., M H Bar, David H. Boldt, et al.. (1989). Phase i study of high dose continuous infusion interleukin 2 and autologous lymphokine activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma. 30. 239. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact